{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T23:22:52Z","timestamp":1756682572736,"version":"3.32.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,27]]},"DOI":"10.7759\/cureus.76465","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T13:47:30Z","timestamp":1735307250000},"source":"Crossref","is-referenced-by-count":1,"title":["Tachycardia-Induced Cardiomyopathy Following Prolonged Ritodrine Infusion During Pregnancy: A Case Report"],"prefix":"10.7759","author":[{"given":"Masahiro","family":"Nakao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Takamisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinami","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azumi","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Katsuragi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2018.04.003","article-title":"The global epidemiology of preterm birth","volume":"52","author":"Vogel JP","year":"2018","unstructured":"Vogel JP, Chawanpaiboon S, Moller AB, Watananirun K, Bonet M, Lumbiganon P. The global epidemiology of preterm birth. Best Pract Res Clin Obstet Gynaecol. 2018, 52:3-12. 10.1016\/j.bpobgyn.2018.04.003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/NMC.0000000000000656","article-title":"Preterm labor and birth: a clinical review","volume":"45","author":"Griggs KM","year":"2020","unstructured":"Griggs KM, Hrelic DA, Williams N, McEwen-Campbell M, Cypher R. Preterm labor and birth: a clinical review. MCN Am J Matern Child Nurs. 2020, 45:328-37. 10.1097\/NMC.0000000000000656","journal-title":"MCN Am J Matern Child Nurs"},{"key":"ref3","unstructured":"FDA drug safety communication. new warnings against use of terbutaline to treat preterm labor. (2017). Accessed: December 3, 2024: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-new-warnings-against-use-terbuta...."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jog.15438","article-title":"Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition","volume":"49","author":"Itakura A","year":"2023","unstructured":"Itakura A, Shoji S, Shigeru A, et al.. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2020 edition. J Obstet Gynaecol Res. 2023, 49:5-53. 10.1111\/jog.15438","journal-title":"J Obstet Gynaecol Res"},{"key":"ref5","unstructured":"Guidelines for obstetric care, CQ302. Diagnosis and management of preterm labor (2023). [In Japanese]. (2023). Accessed: December 14, 2024: https:\/\/www.jsog.or.jp\/activity\/pdf\/gl_sanka_2023.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.15549","article-title":"Risks of maternal cardiopulmonary events associated with ritodrine for tocolysis: a national database linkage study in 1\u2009831\u2009564 pregnant women","volume":"167","author":"Lin CW","year":"2024","unstructured":"Lin CW, Chan KA, Chen YY, et al.. Risks of maternal cardiopulmonary events associated with ritodrine for tocolysis: a national database linkage study in 1\u2009831\u2009564 pregnant women. Int J Gynaecol Obstet. 2024, 167:295-305. 10.1002\/ijgo.15549","journal-title":"Int J Gynaecol Obstet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jog.15951","article-title":"Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan","volume":"50","author":"Nakamura M","year":"2024","unstructured":"Nakamura M, Sekizawa A, Hasegawa J, et al.. Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan. J Obstet Gynaecol Res. 2024, 50:1111-7. 10.1111\/jog.15951","journal-title":"J Obstet Gynaecol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.045","article-title":"Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Huizar JF","year":"2019","unstructured":"Huizar JF, Ellenbogen KA, Tan AY, Kaszala K. Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019, 73:2328-44. 10.1016\/j.jacc.2019.02.045","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(86)90486-2","article-title":"Electrocardiographic changes associated with ritodrine-induced maternal tachycardia and hypokalemia","volume":"154","author":"Hendricks SK","year":"1986","unstructured":"Hendricks SK, Keroes J, Katz M. Electrocardiographic changes associated with ritodrine-induced maternal tachycardia and hypokalemia. Am J Obstet Gynecol. 1986, 154:921-3. 10.1016\/0002-9378(86)90486-2","journal-title":"Am J Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek V","year":"2018","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al.. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018, 39:3165-241. 10.1093\/eurheartj\/ehy340","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0000000000000209","article-title":"Tachycardia-induced cardiomyopathy in pregnancy","volume":"17","author":"Joseph AC","year":"2016","unstructured":"Joseph AC, Prapa M, Pellicori P, Mabote T, Nasir M, Clark AL. Tachycardia-induced cardiomyopathy in pregnancy. J Cardiovasc Med (Hagerstown). 2016, 17:762-6. 10.2459\/JCM.0000000000000209","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003182","article-title":"Atrial fibrillation and atrial flutter in pregnant women\u2014a population-based study","volume":"5","author":"Lee MS","year":"2016","unstructured":"Lee MS, Chen W, Zhang Z, et al.. Atrial fibrillation and atrial flutter in pregnant women\u2014a population-based study. J Am Heart Assoc. 2016, 5:e003182. 10.1161\/JAHA.115.003182","journal-title":"J Am Heart Assoc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026681","article-title":"Burden of arrhythmia in pregnancy","volume":"135","author":"Vaidya VR","year":"2017","unstructured":"Vaidya VR, Arora S, Patel N, et al.. Burden of arrhythmia in pregnancy. Circulation. 2017, 135:619-21. 10.1161\/CIRCULATIONAHA.116.026681","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2003.10.028","article-title":"Pregnancy and the cardiovascular system","volume":"98","author":"Abbas AE","year":"2005","unstructured":"Abbas AE, Lester SJ, Connolly H. Pregnancy and the cardiovascular system. Int J Cardiol. 2005, 98:179-89. 10.1016\/j.ijcard.2003.10.028","journal-title":"Int J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.49.39","article-title":"Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy","volume":"49","author":"Watanabe H","year":"2008","unstructured":"Watanabe H, Okamura K, Chinushi M, Furushima H, Tanabe Y, Kodama M, Aizawa Y. Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy. Int Heart J. 2008, 49:39-47. 10.1536\/ihj.49.39","journal-title":"Int Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof P","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al.. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016, 37:2893-962. 10.1093\/eurheartj\/ehw210","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.02.049","article-title":"Histopathological and immunological characteristics of tachycardia-induced cardiomyopathy","volume":"69","author":"Mueller KA","year":"2017","unstructured":"Mueller KA, Heinzmann D, Klingel K, et al.. Histopathological and immunological characteristics of tachycardia-induced cardiomyopathy. J Am Coll Cardiol. 2017, 69:2160-72. 10.1016\/j.jacc.2017.02.049","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000135472.28234.CC","article-title":"Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia","volume":"110","author":"Nerheim P","year":"2004","unstructured":"Nerheim P, Birger-Botkin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation. 2004, 110:247-52. 10.1161\/01.CIR.0000135472.28234.CC","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/PTS.0b013e3181dcaf32","article-title":"Single-parameter early warning criteria to predict life-threatening adverse events","volume":"6","author":"Rothschild JM","year":"2010","unstructured":"Rothschild JM, Gandara E, Woolf S, Williams DH, Bates DW. Single-parameter early warning criteria to predict life-threatening adverse events. J Patient Saf. 2010, 6:97-101. 10.1097\/PTS.0b013e3181dcaf32","journal-title":"J Patient Saf"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217864","article-title":"Early warning systems in obstetrics: a systematic literature review","volume":"14","author":"Umar A","year":"2019","unstructured":"Umar A, Ameh CA, Muriithi F, Mathai M. Early warning systems in obstetrics: a systematic literature review. PLoS One. 2019, 14:e0217864. 10.1371\/journal.pone.0217864","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-011-0729-x","article-title":"The predictive value of physical examination findings in patients with suspected acute heart failure syndrome","volume":"7","author":"Jang TB","year":"2012","unstructured":"Jang TB, Aubin C, Naunheim R, Lewis LM, Kaji AH. The predictive value of physical examination findings in patients with suspected acute heart failure syndrome. Intern Emerg Med. 2012, 7:271-4. 10.1007\/s11739-011-0729-x","journal-title":"Intern Emerg Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/325680-tachycardia-induced-cardiomyopathy-following-prolonged-ritodrine-infusion-during-pregnancy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T13:47:34Z","timestamp":1735307254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/325680-tachycardia-induced-cardiomyopathy-following-prolonged-ritodrine-infusion-during-pregnancy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.76465","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,27]]}}}